Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Late-onset agranulocytosis in a patient with schizophrenia after 17 months of clozapine treatment.

Bhanji NH, Margolese HC, Chouinard G, Turnier L.

J Clin Psychopharmacol. 2003 Oct;23(5):522-3. No abstract available.

PMID:
14520134
2.

Genetic factors in clozapine-induced agranulocytosis.

Reznik I, Mester R.

Isr Med Assoc J. 2000 Nov;2(11):857-8. Review. No abstract available.

3.

Clozapine.

[No authors listed]

Lancet. 1989 Dec 16;2(8677):1430-2. Review. No abstract available.

PMID:
2574365
4.

[Clozapine-induced agranulocytosis: genetic risk factors and an immunologic explanatory model].

Güzelcan Y, Scholte WF.

Tijdschr Psychiatr. 2006;48(4):295-302. Review. Dutch.

5.

[Clozapine in the treatment of under-age schizophrenia].

Haapasalo-Pesu KM.

Duodecim. 2009;125(15):1635-8. Review. Finnish.

PMID:
19769179
6.
7.

Suicide in schizophrenia, clozapine, and adoption of evidence-based medicine.

Meltzer HY.

J Clin Psychiatry. 2005 Apr;66(4):530-3. Review. No abstract available.

PMID:
15816797
8.

Clozapine use in children and adolescents.

Gogtay N, Rapoport J.

Expert Opin Pharmacother. 2008 Feb;9(3):459-65. doi: 10.1517/14656566.9.3.459 . Review.

PMID:
18220495
9.

The safety of clozapine in the elderly.

Gareri P, De Fazio P, Russo E, Marigliano N, De Fazio S, De Sarro G.

Expert Opin Drug Saf. 2008 Sep;7(5):525-38. doi: 10.1517/14740338.7.5.525 . Review.

PMID:
18759705
10.

Clozapine-induced serositis: review of its clinical features, pathophysiology and management strategies.

Mouaffak F, Gaillard R, Burgess E, Zaki H, Olié JP, Krebs MO.

Clin Neuropharmacol. 2009 Jul-Aug;32(4):219-23. doi: 10.1097/WNF.0b013e318197a2f2. Review.

PMID:
19620851
11.

Combination of clozapine and amisulpride in treatment-resistant schizophrenia--case reports and review of the literature.

Zink M, Knopf U, Henn FA, Thome J.

Pharmacopsychiatry. 2004 Jan;37(1):26-31. Review.

PMID:
14750045
12.

On the possible mechanisms and predictability of clozapine-induced agranulocytosis.

Pisciotta AV, Konings SA, Ciesemier LL, Cronkite CE, Lieberman JA.

Drug Saf. 1992;7 Suppl 1:33-44. Review.

PMID:
1503676
13.

[Leponex, 10 years after -- a clinical review].

Llorca PM, Pere JJ.

Encephale. 2004 Sep-Oct;30(5):474-91. Review. French.

PMID:
15627052
14.

Leponex--associated granulocytopenia: a review of the situation.

Krupp P, Barnes P.

Psychopharmacology (Berl). 1989;99 Suppl:S118-21. Review. No abstract available.

PMID:
2682727
15.

[Agranulocytosis].

[No authors listed]

Policlinico Prat. 1970 Dec 14;77(50):1641-2. Review. Italian. No abstract available.

PMID:
9082356

Supplemental Content

Support Center